3/25
11:10 am
ghrs
GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD
Low
Report
GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD
3/25
01:44 am
ghrs
What Does GH Research PLC (GHRS)'s Clinical Progress Updates Say? [Yahoo! Finance]
Low
Report
What Does GH Research PLC (GHRS)'s Clinical Progress Updates Say? [Yahoo! Finance]
3/10
05:32 pm
ghrs
GH Research FY25 Results: Strong Cash Position As GH001 Advances Toward Phase 3 [Seeking Alpha]
Medium
Report
GH Research FY25 Results: Strong Cash Position As GH001 Advances Toward Phase 3 [Seeking Alpha]
3/10
10:09 am
ghrs
GH Research (GHRS) was given a new $34.00 price target by Guggenheim.
Low
Report
GH Research (GHRS) was given a new $34.00 price target by Guggenheim.
3/6
08:29 am
ghrs
GH Research (GHRS) had its price target raised by Citizens Jmp from $39.00 to $42.00. They now have a "market outperform" rating on the stock.
Medium
Report
GH Research (GHRS) had its price target raised by Citizens Jmp from $39.00 to $42.00. They now have a "market outperform" rating on the stock.
3/6
08:03 am
ghrs
GH Research (GHRS) had its price target raised by Needham & Company LLC from $31.00 to $32.00. They now have a "buy" rating on the stock.
Medium
Report
GH Research (GHRS) had its price target raised by Needham & Company LLC from $31.00 to $32.00. They now have a "buy" rating on the stock.
3/5
05:39 pm
ghrs
GH Research GAAP EPS of -$0.79 [Seeking Alpha]
Medium
Report
GH Research GAAP EPS of -$0.79 [Seeking Alpha]
3/5
07:24 am
ghrs
GH Research Reports Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
GH Research Reports Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
3/5
07:00 am
ghrs
GH Research Reports Full Year 2025 Financial Results and Provides Business Update
Medium
Report
GH Research Reports Full Year 2025 Financial Results and Provides Business Update
3/2
08:56 am
ghrs
GH Research (GHRS) had its price target raised by HC Wainwright from $35.00 to $70.00. They now have a "buy" rating on the stock.
Medium
Report
GH Research (GHRS) had its price target raised by HC Wainwright from $35.00 to $70.00. They now have a "buy" rating on the stock.
1/23
10:20 am
ghrs
GH Research (NASDAQ:GHRS) had its price target raised by analysts at Royal Bank Of Canada from $33.00 to $40.00. They now have an "outperform" rating on the stock.
Low
Report
GH Research (NASDAQ:GHRS) had its price target raised by analysts at Royal Bank Of Canada from $33.00 to $40.00. They now have an "outperform" rating on the stock.
1/6
09:02 am
ghrs
GH Research (NASDAQ:GHRS) was given a new $29.00 price target on by analysts at Needham & Company LLC.
High
Report
GH Research (NASDAQ:GHRS) was given a new $29.00 price target on by analysts at Needham & Company LLC.
1/6
08:42 am
ghrs
GH Research (NASDAQ:GHRS) was given a new $39.00 price target on by analysts at Wolfe Research.
High
Report
GH Research (NASDAQ:GHRS) was given a new $39.00 price target on by analysts at Wolfe Research.
1/6
08:42 am
ghrs
GH Research (NASDAQ:GHRS) was given a new $39.00 price target on by analysts at Canaccord Genuity Group Inc..
High
Report
GH Research (NASDAQ:GHRS) was given a new $39.00 price target on by analysts at Canaccord Genuity Group Inc..
1/6
07:07 am
ghrs
GH Research (NASDAQ:GHRS) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
GH Research (NASDAQ:GHRS) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
1/5
02:10 pm
ghrs
GH Research (NASDAQ:GHRS) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Low
Report
GH Research (NASDAQ:GHRS) had its "buy" rating reaffirmed by analysts at Cowen Inc.
1/5
11:07 am
ghrs
GH Research (NASDAQ:GHRS) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
GH Research (NASDAQ:GHRS) had its "buy" rating reaffirmed by analysts at Guggenheim.
1/5
08:02 am
ghrs
GH Research (NASDAQ:GHRS) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $19.00 price target on the stock.
High
Report
GH Research (NASDAQ:GHRS) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $19.00 price target on the stock.
1/5
07:54 am
ghrs
GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026 [Yahoo! Finance]
High
Report
GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026 [Yahoo! Finance]
1/5
07:00 am
ghrs
GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026
Low
Report
GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026
1/4
08:31 am
ghrs
GH Research: GH001 Shows Robust Data Ahead Of FDA IND Decision [Seeking Alpha]
Medium
Report
GH Research: GH001 Shows Robust Data Ahead Of FDA IND Decision [Seeking Alpha]
1/2
04:26 pm
ghrs
GH Research to Announce IND Status for GH001 [Yahoo! Finance]
Medium
Report
GH Research to Announce IND Status for GH001 [Yahoo! Finance]
1/2
04:01 pm
ghrs
GH Research to Announce IND Status for GH001
High
Report
GH Research to Announce IND Status for GH001